Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Diabetes
Recent news which mentions Diabetes
< Previous
1
2
3
4
Next >
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
August 19, 2025
Tickers
GDRX
NEWS
NVO
Tags
Health Care
Market News
Stories That Matter
From
Benzinga
ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday
July 08, 2025
Tickers
NEWS
PROK
Tags
News
ProKidney
Equities
From
Benzinga
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
June 24, 2025
Tickers
AMGN
NEWS
Tags
Benzinga
Analyst Color
Biotech
From
Benzinga
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
June 02, 2025
Tickers
ABT
BBNX
DXCM
NEWS
Tags
Benzinga
why it's moving
Analyst Color
From
Benzinga
Medtronic Beats Q4 Forecasts, Hikes Dividend, Plans Diabetes Spinoff
May 21, 2025
Tickers
ABEQ
CVRD
MDT
NEWS
Tags
MDT
ABEQ
Market News
From
Benzinga
Bill Ackman Calls Out Coca-Cola, Pepsi Over Obesity Crisis — Ross Gerber Notes 'He Owns Several Crap Food Companies'
February 11, 2025
Tickers
CMG
HLT
KO
LOW
Tags
CMG
Market News
Equities
From
Benzinga
Could Cannabis Compounds Outperform Diabetes Drugs? Early Findings Show Potential, But More Research Is Needed
February 10, 2025
Tickers
NEWS
Tags
New Study
Benzinga
News
From
Benzinga
Alcohol and Cancer, Sugary Drinks and Diabetes, and Ketamine and Depression
January 28, 2025
Tags
diabetes
Doc Gumshoe
alcohol
From
Stock Gumshoe
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Science
Health & Science
Medical research
From
CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
Tickers
NEWS
NVO
Tags
Health Care
Market News
Bernie Sanders
From
Benzinga
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
August 31, 2024
Tickers
DRUG
NEWS
NVO
Tags
News
General
NVO
From
Benzinga
CNBC Daily Open: A 'crazy' summer
August 21, 2024
Tags
Breaking News: Business
Stock markets
Inflation
From
CNBC.com News
CNBC Daily Open: 'Crazy' summer
August 20, 2024
Tags
Morgan Stanley
Obesity
BYD Co Ltd
From
CNBC.com News
Can Cannabis Help Prevent Diabetes? New Study Shows Potential Benefits
July 15, 2024
Tickers
CCC
Tags
Market News
Health Care
Cannabis
From
Benzinga
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Novo Nordisk A/S
stocks
ETF Edge
From
CNBC.com News
Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More
June 26, 2024
Tickers
GLP
NEWS
NVO
Tags
Politics
Ozempic
Benzinga
From
Benzinga
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials
June 07, 2024
Tickers
BMEA
NEWS
Tags
Pre/Market Outlook
Diabetes
News
From
Benzinga
Usher says early detection could have better prepared his family for a Type 1 diabetes diagnosis—97% of caregivers agree
June 05, 2024
Tags
Health
Health Tips and Wellness Advice
Make It / Life
From
CNBC.com News
Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report
May 27, 2024
Tickers
LLY
NEWS
NVO
Tags
Benzinga
Market News
Health Care
From
Benzinga
Eli Lilly's Weekly Insulin Dose On Par With Commonly Used Daily Doses, Phase 3 Studies Show
May 16, 2024
Tickers
LLY
NEWS
Tags
Health Care
Market News
Biotech
From
Benzinga
Nova Biomedical New Generation StatStrip Glucose Hospital Meter Obtains FDA 510k Clearance
March 25, 2024
Tickers
ICU
Tags
Diabetes
Glucose Meter
Icu
From
PRLog
DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says
March 12, 2024
Tickers
DXCM
NEWS
Tags
Top Stories
News
Diabetes
From
Benzinga
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
Diabetes
Health Care IT
Drug trials
From
CNBC.com News
Low-Fat Milk vs. Yogurt, Declining Health, More BMI Skepticism… and What Makes Us Itch?
February 15, 2024
Tags
cardiovascular disease
Doc Gumshoe
inflammation
From
Stock Gumshoe
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
Tickers
ALT
LLY
NVO
PFE
Tags
wegovy
pharmaceutical stocks
Bernie Sanders
From
Benzinga
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Health care industry
Diabetes
Biotech and Pharmaceuticals
From
CNBC.com News
Ozempic Supply Is Running Low: Here's Why That Can Be A Problem
October 31, 2023
Tickers
LLY
NVO
Tags
Diabetes
Health Care
NVO
From
Benzinga
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Health insurance
Weight management
Wall Street
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
US: News
Business
CEO
From
CNBC.com News
Give diabetes the finger! New fingerprick test could save 10 million life-years and 5,000 amputations
September 27, 2023
Tags
Diabetes
Putney
Healthcare
From
PRLog
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.